Victor Guanowsky

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 322 citations

Medicine, Pharmacology, Pharmacotherapy +15

Reduction of Brain Kynurenic Acid Improves Cognitive Function

Rouba Kozak, Brian Campbell, Christine A. Strick et al. · Journal of Neuroscience · 2014 · 178 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

Judith A. Siuciak, Douglas S. Chapin, Sheryl A. McCarthy et al. · Neuropharmacology · 2006 · 132 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Atropisomeric quinazolin-4-one derivatives are potent noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists

W. M. WELCH, Frank E. Ewing, J. HUANG et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 125 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

Hans Rollema, Mihály Hajós, Patricia A. Seymour et al. · Biochemical Pharmacology · 2009 · 116 citations

Medicine, Neuroscience, Pharmacology +10